Variability in plasma rifampicin concentrations and role of SLCO1B1, ABCB1, AADAC2 and CES2 genotypes in Ethiopian patients with tuberculosis

Tesemma Sileshi,Eyasu Makonnen,Nigus Fikrie Telele,Victoria Barclay,Alimuddin Zumla,Eleni Aklillu
DOI: https://doi.org/10.1080/23744235.2024.2309348
2024-02-07
Infectious Diseases
Abstract:Background Rifampicin, a key drug against tuberculosis (TB), displays wide between-patient pharmacokinetics variability and concentration-dependent antimicrobial effect. We investigated variability in plasma rifampicin concentrations and the role of SLCO1B1 , ABCB1 , arylacetamide deacetylase ( AADAC ) and carboxylesterase 2 ( CES-2 ) genotypes in Ethiopian patients with TB.
infectious diseases
What problem does this paper attempt to address?